This brand name is authorized in Nigeria.
The drug GLACIPTIZOLE contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
|
|
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
|
2
|
UNII
033KF7V46H - TINIDAZOLE
|
|
Tinidazole is active against both protozoa and obligate anaerobic bacteria. The activity against protozoa involves Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. The mode of action of tinidazole against anaerobic bacteria and protozoa involves penetration of the drug into the cell of the micro-organism and subsequent damage of DNA strands or inhibition of their synthesis. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-3925 | Tablet | GLACIPTIZOLE TABLET TAB 500 mg; 600 mg 110 | GLACIPTIZOLE TABLET CIPROFLOXACIN HYDROCHLORIDE USP 500MG & TINIDAZOLE 600MG ACTIVE INGREDIENTS: Ciprofloxacin Hydrochloride USP 500mg Tinidazole 600mg LIST OF EXCIPIENTS: Maize starch Purified water Purified Talc Sodium starch glycolate Magnesium stearate Colloiodal anhydrous silica Colorezy white Colour sunset yellow Isopropyl alcohol Dichloromethan B4-3925 Drugs Imported Products 110 Prescription Only Medicine (POM) 07/01/2021 GLACK PHARM. LIMITED, NO. 22, STELLA OSHOLAKE STREET, OFF INTERNATIONAL AIRPORT ROAD, AJAO ESTATE, ISOLO, LAGOS STATE 2.34704E+12 ugoglac2017@gmail.com M/S MEDICO REMEDIES PVT LTD, 8 & 9, DEWAN & SONS, UDYOG NAGAR, LOKMANYA NAGAR, PALGHAR (WEST), DIST. THANE, MAHARASHTRA, INDIA., India | 31/08/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01RA11 | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01R Combinations of antibacterials → J01RA Combinations of antibacterials | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-3925 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.